Leuprorelin

Amber-G

Brand Name(s):Staladex

Indication:Hormone-dependent, advanced prostate cancer. High risk, localized and locally advanced, hormone-dependent prostate cancer in combination with radiotherapy.

Rationale:

Considered:Jan-20

Review Date:Sep-22

Comments:
NICE CG175
Prostate cancer:diagnosis & treatment:http://www.nice.org.uk/nicemedia/live/14348/66226/66226.pdf
Jan 2014
…………………………
For full guidance and monitoring requirements please refer to the “Guidance for the Prescribing of Goserelin, Leuprorelin & Triptorelin in the treatment of Prostate Cancer” paper which can be found in the Guidelines (Local) section of the NHS Doncaster Medicines Management Website